Scientific advice meeting – 26th November 2015

Home » Progress » Uncategorized » Scientific advice meeting – 26th November 2015

Following discussions and formal scientific advice from the German national regulatory authority (Paul-Ehrlich Institute; PEI), the CDVAX consortium has obtained validation of its the preclinical and clinical development strategy in readiness to launch the first-in-man study. A technical batch of CDVAX product is already available and the GLP-compliant toxicology studies and GMP production of the CDVAX will be launched imminently.

Leave a Comment